Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Obagi Medical Products, Inc.
| Metric | Obagi Medical Products, Inc. Healthcare |
|---|---|
| Quality Score | 87 / 100 |
| Revenue (latest) | $31M |
| Net income (latest) | $17M |
| Operating margin | 89.2% |
| Net margin | 54.1% |
| Return on equity | 26.9% |
| Return on assets | 20.3% |
| Return on capital (ROCE) | 43.1% |
| Debt / equity | 0.33× |
| Revenue growth (YoY) | 16.0% |
| Altman Z″ (distress) | 11.39 |
| Accruals / assets | −4.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.